First Completed Microbial Genomes Signal Birth Of New Area Of Study

Study Author: Karen Young Kreeger Researchers have been comparing parts of genomes at the individual gene level for years. Portions of the genomes of tens of thousands of species-from bacteria to humans-reside in private and public databases around the world. Pharmaceutical scientists sift through these collections, panning for potential drugs and therapies, while basic investigators in an array of fields search for similarities and differences in the species' blueprints for life. But what re

Written byKaren Young Kreeger
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Study Author: Karen Young Kreeger

Researchers have been comparing parts of genomes at the individual gene level for years. Portions of the genomes of tens of thousands of species-from bacteria to humans-reside in private and public databases around the world. Pharmaceutical scientists sift through these collections, panning for potential drugs and therapies, while basic investigators in an array of fields search for similarities and differences in the species' blueprints for life.

But what researchers haven't had available to examine until a short while ago is the complete genetic road map of a free-living species.

IN ITS ENTIRETY: Mycoplasma genitalium, denoted by arrow in left figure, was fully sequenced by three teams, one led by UNC's Clyde Hutchison. These much-prized data became available with the recent publication of the first two full genomes derived from independent organisms. In July, a collaboration of two teams-one headed by J. Craig Venter, president of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies